Australia's largest stock trading and investment forum Australia's #1 stock forum

MNQ

0.00%

0.0¢ minquest limited

Ann: Appendix 3B, page-5

First 5 Last

Master Burrows

3,538 Posts.

13/08/15

02:58

Post #: 15797667

Originally posted by itsonlyme ↑

Wow look at all the bids disappear!

Column 1 Column 2 Column 3 Column 4 Column 5 Column 6

1 1 100,000 0.025 0.030 20,314 1

2 1 250,000 0.017 0.033 200,000 2

3 1 250,000 0.016 0.034 100,000 1

4 1 450,000 0.014 0.035 100,000 1

5 1 550,000 0.013 0.037 50,000 1

6 1 500,000 0.012 0.041 130,000 1

7 1 500,000 0.011 0.043 100,000 1

8 1 250,000 0.010 0.045 30,000 1

9 0.050 25,000 1

10 0.080 125,000 1

Expand

Seems to me the share price is tightly controlled by Pattos and Pershing clients - my broker trading data for the past month suggests this

Also seems to me the buy and sell depth is deliberately presented in a way so that short term traders are put off from entering, with volume kept low

As others here have suggested - if news gets released and looks favourable, the share price will do all the talking

MNQ Price at posting: 2.6¢ Sentiment: None Disclosure: Held

2 Upvote

0 Great analysis

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ETM

Energy Transition Mins' frustrated as mammoth lawsuit against Greenland inches forward; shares dip -12%

LDX

Lumos gains US govt support for study on FebriDx bacterial infection test

First 5 Last

Add MNQ (ASX) to my watchlist

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6
1	1	100,000	0.025	0.030	20,314	1
2	1	250,000	0.017	0.033	200,000	2
3	1	250,000	0.016	0.034	100,000	1
4	1	450,000	0.014	0.035	100,000	1
5	1	550,000	0.013	0.037	50,000	1
6	1	500,000	0.012	0.041	130,000	1
7	1	500,000	0.011	0.043	100,000	1
8	1	250,000	0.010	0.045	30,000	1
9				0.050	25,000	1
10				0.080	125,000	1

Ann: Appendix 3B, page-5

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Energy Transition Mins' frustrated as mammoth lawsuit against Greenland inches forward; shares dip -12%

Lumos gains US govt support for study on FebriDx bacterial infection test

Featured News